The growth of antibiotic injections declined and the carbon Penicillium fell

Custom Synthesis, As a kind of atypical beta-caprolactam antibiotics, the carbon-Penicillium-type antibiotics published in the 1980s, its characteristics are: broad-spectrum, strong effect, low rate of bacterial resistance, but it also has many adverse reactions, serious can lead to leukopenia, neutrophil reduction and nervous system toxicity, muscle spasm, insanity , tremor, muscle spasm or epilepsy.

In the gradual escalation of antibiotic use, to curb the expansion of the use of South-type drugs should not be underestimated. In recent years, with the implementation of “national restrictive policy”, the trend of the whole body using antimicrobial drugs has been effectively curbed.

The 2012 ~2013 Antibiotic hospital market in a straight line of decline, so that the growth rate tends to normalized. So far, there are 7 of the world’s listed carbon-penicillium drugs, one of the unilateral drugs are the United States Faropenem, compared to Biapenem, Ernie-South, Niepenand and the south of the 5 varieties, the compound is imipenem/cilastatin, Parni pui-lung/betamethasone.

Under the influence of patent expiry and generic drug listing, foreign market sales have plummeted from their peak.

According to relevant data, 2016 the global TOP3 of carbon penicillium drugs, the original Research brand drug market market for 1.008 billion U.S. dollars, with the last year flat, which for the imitation of the pharmaceutical market has brought new opportunities for development. According to the meter intranet data show that 2016 domestic public medical institutions, carbon penicillium antibiotic drugs market sales have exceeded 10 billion yuan, overall, imported varieties and domestic varieties have formed two against the situation. However, under the 2017 anti-tube notice, the domestic public medical institutions, the carbon-penicillium antibiotic drugs market shows a downturn.